KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacira BioSciences (PCRX) Amortization - Intangibles (2019 - 2025)

Historic Amortization - Intangibles for Pacira BioSciences (PCRX) over the last 7 years, with Q3 2025 value amounting to $14.3 million.

  • Pacira BioSciences' Amortization - Intangibles changed 0.0% to $14.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $57.3 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $57.3 million for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Pacira BioSciences' Amortization - Intangibles stood at $14.3 million, which was down 0.0% from $14.3 million recorded in Q2 2025.
  • Over the past 5 years, Pacira BioSciences' Amortization - Intangibles peaked at $14.3 million during Q1 2022, and registered a low of $2.0 million during Q1 2021.
  • For the 5-year period, Pacira BioSciences' Amortization - Intangibles averaged around $12.0 million, with its median value being $14.3 million (2022).
  • In the last 5 years, Pacira BioSciences' Amortization - Intangibles changed by 0.0% in 2021 and then soared by 61610.0% in 2022.
  • Over the past 5 years, Pacira BioSciences' Amortization - Intangibles (Quarter) stood at $7.7 million in 2021, then surged by 86.7% to $14.3 million in 2022, then rose by 0.08% to $14.3 million in 2023, then changed by 0.0% to $14.3 million in 2024, then grew by 0.15% to $14.3 million in 2025.
  • Its last three reported values are $14.3 million in Q3 2025, $14.3 million for Q2 2025, and $14.3 million during Q1 2025.